» Articles » PMID: 37665656

Childhood Schizotypy and Adolescent Mental Disorder

Overview
Journal Schizophr Bull
Specialty Psychiatry
Date 2023 Sep 4
PMID 37665656
Authors
Affiliations
Soon will be listed here.
Abstract

Background And Hypothesis: Schizotypy provides a framework for understanding the developmental nature of psychotic disorders and a means of identifying "at-risk" individuals early in the lifespan. However, there is a lack of prospective longitudinal research examining the relationship between schizotypy in childhood and later psychotic and other mental disorders. We hypothesized that distinct profiles of schizotypy in childhood would be differentially associated with psychotic and other mental disorders emerging later in adolescence.

Study Design: In a large population cohort of Australian young people (n = 26 837), we prospectively examined the relationship between person-centered profiles of schizotypy identified in middle childhood (age ~11 years) and adolescent diagnoses (age ~13-18 years) across 7 types of mental disorders using multinomial logistic regression.

Results: Membership in any of 3 childhood schizotypy profiles (true schizotypy, affective schizotypy, or introverted schizotypy) was associated with an increased likelihood of being diagnosed with any type of mental disorder in adolescence; effects were strongest for the true schizotypy group (aOR = 3.07, 95% CI = 2.64, 3.57), followed by the introverted (aOR = 1.94, 95% CI = 1.75, 2.15) and affective (aOR = 1.29, 95% CI = 1.13, 1.47) schizotypy groups. Six of the 7 types of mental disorders measured (including psychotic disorders) were associated with at least 1 schizotypy group.

Conclusions: Schizotypy in middle childhood is an important correlate of mental disorders in adolescence; however, it does not appear to be specifically associated with psychotic disorders in this age group.

Citing Articles

Schizotypy, Psychosis Proneness, and the Polygenic Risk for Schizophrenia and Resilience.

Meller T, Lundberg C, Maj C, Hoffmann P, Forstner A, Nothen M Schizophr Bull. 2025; 51(Supplement_2):S85-S94.

PMID: 40037822 PMC: 11879570. DOI: 10.1093/schbul/sbae161.


Neuropsychology and Neurobiology of Negative Schizotypy: A Selective Review.

Wang L, Lui S, Chan R Biol Psychiatry Glob Open Sci. 2024; 4(4):100317.

PMID: 38711865 PMC: 11070600. DOI: 10.1016/j.bpsgos.2024.100317.

References
1.
Jones P . Adult mental health disorders and their age at onset. Br J Psychiatry Suppl. 2013; 54:s5-10. DOI: 10.1192/bjp.bp.112.119164. View

2.
Fisher H, Caspi A, Poulton R, Meier M, Houts R, Harrington H . Specificity of childhood psychotic symptoms for predicting schizophrenia by 38 years of age: a birth cohort study. Psychol Med. 2013; 43(10):2077-86. PMC: 3758773. DOI: 10.1017/S0033291712003091. View

3.
Green M, Watkeys O, Harris F, OHare K, Whitten T, Tzoumakis S . Cohort Profile Update: The New South Wales Child Development Study (NSW-CDS) - Wave 3 (child age ∼18 years). Int J Epidemiol. 2024; 53(3). DOI: 10.1093/ije/dyae069. View

4.
Kirli U, Binbay T, Drukker M, Elbi H, Kayahan B, Keskin Gokcelli D . DSM outcomes of psychotic experiences and associated risk factors: 6-year follow-up study in a community-based sample. Psychol Med. 2018; 49(8):1346-1356. DOI: 10.1017/S0033291718001964. View

5.
Green M, Harris F, Laurens K, Kariuki M, Tzoumakis S, Dean K . Cohort Profile: The New South Wales Child Development Study (NSW-CDS)-Wave 2 (child age 13 years). Int J Epidemiol. 2018; 47(5):1396-1397k. DOI: 10.1093/ije/dyy115. View